Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ibrahim Aldoss

Showing results (101-110 of 233) with videos related to

Pageof 24
Sort By:
Cancer Medicine|April 1, 2025
Quality-Adjusted Time Without Symptoms of Disease or Toxicity (Q-TWiST) in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Comparison of Ponatinib Versus ImatinibAjibade Ashaye, Ling Shi, Ibrahim Aldoss, et al.
Leukemia & Lymphoma|August 19, 2024
The characterization and the impact of CSF pleocytosis during blinatumomab therapy for adult acute lymphoblastic leukemiaDat Ngo, Jose Tinajero, Joo Y Song, et al.
British Journal of Haematology|April 1, 2024
Therapy-related acute lymphoblastic leukaemia in women with antecedent breast cancerHoda Pourhassan, Jianying Zhang, Jose Tinajero, et al.
Journal of Palliative Medicine|September 1, 2011
Effect of palliative care services on the aggressiveness of end-of-life care in the Veteran's Affairs cancer populationWilson I Gonsalves, Tsewang Tashi, Jairam Krishnamurthy, et al.
Annals of Hematology|October 10, 2025
Impact of clinical response and treatment tolerability on HRQoL in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinibAjibade Ashaye, Ling Shi, Ibrahim Aldoss, et al.
Leukemia & Lymphoma|December 9, 2021
Long-term follow-up of patients with poor-risk acute leukemia treated on a phase 2 trial undergoing intensified conditioning regimen prior to allogeneic hematopoietic cell transplantationAmandeep Salhotra, Dongyun Yang, Sally Mokhtari, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 14, 2020
Iron Overload Is Associated with Delayed Engraftment and Increased Nonrelapse Mortality in Recipients of Umbilical Cord Blood Hematopoietic Cell TransplantationMonzr M Al Malki, Joo Y Song, Dongyun Yang, et al.
British Journal of Haematology|November 6, 2024
Delaying pegaspargase during induction in adults with acute lymphoblastic leukaemia is associated with lower risk of high-grade hepatotoxicity without adversely impacting outcomesJose Tinajero, Sharon Xu, Dat Ngo, et al.
American Journal of Hematology|September 10, 2025
The Impact of Cytoreduction on Blinatumomab Outcomes for Relapsed or Refractory B-ALL With High Disease BurdenJose Tinajero, Kim Nguyen, Dat Ngo, et al.
The Lancet. Haematology|December 5, 2024
Frontline treatment of adults with newly diagnosed B-cell acute lymphoblastic leukaemiaIbrahim Aldoss, Gail J Roboz, Renato Bassan, et al.
Pageof 24

Showing results (101-110 of 233) with videos related to

Sort By:
Pageof 24
Cancer Medicine|April 1, 2025
Quality-Adjusted Time Without Symptoms of Disease or Toxicity (Q-TWiST) in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Comparison of Ponatinib Versus ImatinibAjibade Ashaye, Ling Shi, Ibrahim Aldoss, et al.
Leukemia & Lymphoma|August 19, 2024
The characterization and the impact of CSF pleocytosis during blinatumomab therapy for adult acute lymphoblastic leukemiaDat Ngo, Jose Tinajero, Joo Y Song, et al.
British Journal of Haematology|April 1, 2024
Therapy-related acute lymphoblastic leukaemia in women with antecedent breast cancerHoda Pourhassan, Jianying Zhang, Jose Tinajero, et al.
Journal of Palliative Medicine|September 1, 2011
Effect of palliative care services on the aggressiveness of end-of-life care in the Veteran's Affairs cancer populationWilson I Gonsalves, Tsewang Tashi, Jairam Krishnamurthy, et al.
Annals of Hematology|October 10, 2025
Impact of clinical response and treatment tolerability on HRQoL in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinibAjibade Ashaye, Ling Shi, Ibrahim Aldoss, et al.
Leukemia & Lymphoma|December 9, 2021
Long-term follow-up of patients with poor-risk acute leukemia treated on a phase 2 trial undergoing intensified conditioning regimen prior to allogeneic hematopoietic cell transplantationAmandeep Salhotra, Dongyun Yang, Sally Mokhtari, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 14, 2020
Iron Overload Is Associated with Delayed Engraftment and Increased Nonrelapse Mortality in Recipients of Umbilical Cord Blood Hematopoietic Cell TransplantationMonzr M Al Malki, Joo Y Song, Dongyun Yang, et al.
British Journal of Haematology|November 6, 2024
Delaying pegaspargase during induction in adults with acute lymphoblastic leukaemia is associated with lower risk of high-grade hepatotoxicity without adversely impacting outcomesJose Tinajero, Sharon Xu, Dat Ngo, et al.
American Journal of Hematology|September 10, 2025
The Impact of Cytoreduction on Blinatumomab Outcomes for Relapsed or Refractory B-ALL With High Disease BurdenJose Tinajero, Kim Nguyen, Dat Ngo, et al.
The Lancet. Haematology|December 5, 2024
Frontline treatment of adults with newly diagnosed B-cell acute lymphoblastic leukaemiaIbrahim Aldoss, Gail J Roboz, Renato Bassan, et al.
Pageof 24